Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa

An in vitro pharmacokinetic model was used to determine if aztreonam could enhance the pharmacodynamics of cefepime or ceftazidime against an isogenic panel of Pseudomonas aeruginosa 164, including wild-type (WT), partially derepressed (PD), and fully derepressed (FD) phenotypes. Logarithmic-phase c...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lister, Philip D., Sanders, W. Eugene, Sanders, Christine C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105655/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9660993/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.7.1610
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!